Placement & SPP to raise $8 million
Filed with ASX · · 6 pages · English
Summary by 6ix AI
Recce Pharmaceuticals Ltd. has announced a capital raising initiative through an institutional placement and a share purchase plan to raise funds. Funds will be allocated to strengthen the balance sheet, support clinical trials, and provide general working capital. The placement has garnered strong support from institutional investors, and the share purchase plan will allow eligible shareholders to participate on the same terms.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Recce Pharmaceuticals Ltd. on 6ix
In the deck
Story so far
Earlier from Recce Pharmaceuticals
- HREC Approval Accelerates Global Phase 3 DFI Strategy
- Addendum to Recce Signs Middle East Licensing Term Sheet
- Recce Signs Middle East Licensing Term Sheet
- Brazil Patent Granted for RECCE Anti-Infectives
- RCE Investor Webinar Presentation Deck
Later from Recce Pharmaceuticals
- AUD $3.7M Income Tax Refund Received
- Vietnamese Patent Granted for RECCE Anti-Infectives
- HREC Approves Comparator Study for Pivotal Phase 3 DFI
- Appendix 4E and FY26 Annual Report
- Amendments to Debt Facility with Avenue Capital Group
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals